UC Berkeley and UCSF launch Computational Biomedicine Initiative
The new Berkeley-UCSF partnership will accelerating advances in clinical care by combining computing and medicine.
“We have been moving in the direction of thinking about CRISPR as a platform for some years,” said Jennifer Doudna, a professor, Nobel laureate and founder of the Innovative Genomics Institute. The article also quotes Fyodor Urnov, a scientific director of the institute.
Fyodor Urnov is part of the team that worked on a novel, on-demand CRISPR theray to treat a newborn boy diagnosed at birth with a rare and potentially fatal genetic disease.
“We made all three major groups of human milk oligosaccharides,” said Patrick Shih, an assistant professor in the Department of Plant & Microbial Biology.
With a millennia-long record of ritual and ceremonial use, psilocybin's potential to treat certain mental disorders has seen new research interest.